![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Rilpivirine efficacy, virology and safety in antiretroviral treatment-naïve patients with baseline viral load ≤100,000 HIV-1 RNA copies/mL: ECHO and THRIVE 96-week pooled dataset
|
|
|
Reported by Jules Levin
Glasgow Nov 11-15 2012
Jean-Michel Molina,1 Nathan Clumeck,2 Chloe Orkin,3 Laurence T Rimsky,4 Simon Vanveggel,4 Marita C Stevens4
1Department of Infectious Diseases, Saint-Louis Hospital and University of Paris Diderot, Paris, France; 2Saint-Pierre University Hospital, Brussels, Belgium; 3Barts and The London NHS Trust, London, UK; 4Janssen Infectious Diseases BVBA, Beerse, Belgium
![AASLD1.gif](../images/112612/122612-10/AASLD1.gif)
![AASLD2.gif](../images/112612/122612-10/AASLD2.gif)
![AASLD3.gif](../images/112612/122612-10/AASLD3.gif)
![AASLD4.gif](../images/112612/122612-10/AASLD4.gif)
![AASLD5.gif](../images/112612/122612-10/AASLD5.gif)
![AASLD6.gif](../images/112612/122612-10/AASLD6.gif)
![AASLD7.gif](../images/112612/122612-10/AASLD7.gif)
![AASLD8.gif](../images/112612/122612-10/AASLD8.gif)
![AASLD9.gif](../images/112612/122612-10/AASLD9.gif)
![AASLD10.gif](../images/112612/122612-10/AASLD10.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|